Skip to content

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

Drug Patent Expirations for the Week of February 8, 2026

By / February 10, 2026

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

IZERVAY (avacincaptad pegol sodium)

Astellas Patent: 9,617,546 Expiration: Feb 14, 2026

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

Related Posts:

Secure the Future of Branded Generics
Maximizing GLP-1 Market Exclusivity: Leveraging…
Sell More After Patents Die
How Pharmaceutical Packaging Companies can Win the…
The Industrialization of Telehealth: A Strategic…
How to Survive the GLP-1 Patent War: A Strategic…
Master the Patent Cliff for Better Pharmacy Margins
Post-LOE? Win the War in the “Inactive” Ingredients:…
Buy Low, Dispense High
Pharma Doesn’t Buy on Features. They Buy on Fear of…
The Defensive Architecture of Biopharmaceutical…
Cut Costs, Not Quality: How excipient vendors can…
Beat the Patent Thicket
Own the Generic Entry Timeline: From Orange Book…
How to keep your drug on the market for five extra years
Win the Patent Cliff: How the 12-Year Biologic…
Win the Patent Cliff: How to Track Patent Expiry and…
The Data-Driven Guide to Winning the 2026 Patent Cliff
Profit from the Patent Gap
Profit From Weak Drug Patents: Identifying Weak…
Sell More Packaging Before Patents Die: Target drug…
Quantifying Patent Risk: How to Factor PTRS into…
The Patent Playbook for Pharma: Protect Your Drug.…
Policy Solutions to End Patent Thickets: Examining…

Uncovering the Success Patterns in Modern Paragraph IV Litigation

The Analyst’s Quandary: Turning Fragmented Data into Alpha

Related Posts

Drug Patent Expirations for the Week of January 4, 2026

Patent Expiration / By

Drug Patent Expirations for the Week of January 18, 2026

Patent Expiration / By

Make Better Decisions

See Plans & Pricing

Recent Posts

Slash drug discovery timelines with GPT-Rosalind
Sell Before the Drug Patent Expiration Cliff: A guide for Commercial & Market Access Vendors using anticipated Loss of Exclusivity dates to offer contracting strategy support before generic entry
Authorized Generics: The Innovator’s Playbook for Diluting First-Filer Profits
Read the Clock Right: Mapping Regulatory Exclusivities for True Generic Drug Entry Timing
Win the Patent War Before the Drug Goes Generic: How Paragraph IV Challenges and Pay-for-Delay Settlements Decide Who Gets Paid — and Who Gets Blocked

Popular Posts

CHEMOCENTRYX, INC. v. ZYDUS PHARMACEUTICALS (USA) INC.
A Definitive Guide to Valuing Pharmaceutical and Biotech Companies
Patent Expiration Dates: The Calendar Every Pharmaceutical Investor Watches
Maximizing Pharmaceutical Patent Longevity: A Mechanistic and Strategic Guide to IP Term Extension and Lifecycle Fortification
Brazilian Pharmaceuticals 2026: The Innovation & Patent Cliff Frontier
China’s Irreplaceable Role in the Global Generic Drug API Supply Chain (2026 Report)
Drug Patent Expiration: The Complete Strategic Guide to Loss of Exclusivity, Lifecycle Management, and the $400 Billion Cliff
When Blockbusters Fall, Business Development Rises: Win the Patent Cliff
The $236 Billion Cliff: How Pharma Loses Its Blockbusters—and What Replaces Them
The IRA Price Reset: What It Actually Does to Pharma Pricing, and What Comes Next

Copyright © 2026 DrugPatentWatch - Transform Data into Market Domination

DrugPatentWatch - Transform Data into Market Domination

Subscribe to Free Updates

3,000+ other biopharma execs get our Drug Patent Expiration Alerts. You should too!

Get fresh news and insights, drug patent expirations & more…

EmailEnter your email address

Thanks, I’m not interested

Last Updated on February 10, 2026 by